Recombinant human single-chain MHC-peptide complexes made from E. coli By in vitro refolding: functional single-chain MHC-peptide complexes and tetramers with tumor associated antigens.

scientific article published in December 2000

Recombinant human single-chain MHC-peptide complexes made from E. coli By in vitro refolding: functional single-chain MHC-peptide complexes and tetramers with tumor associated antigens. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/1521-4141(2000012)30:12<3522::AID-IMMU3522>3.0.CO;2-D
P698PubMed publication ID11093172

P2093author name stringD Segal
C J Cohen
Y Reiter
A F Kirkin
G Denkberg
P2860cites workQuantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramersQ27485114
Phenotypic analysis of antigen-specific T lymphocytesQ28290058
Creating and engineering human antibodies for immunotherapyQ30874943
Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificityQ36142259
Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytesQ36401622
Formation of functional peptide complexes of class II major histocompatibility complex proteins from subunits produced in Escherichia coliQ36647585
A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.Q36807094
HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptidesQ36954248
A recombinant, soluble, single-chain class I major histocompatibility complex molecule with biological activityQ37291950
Peptides naturally presented by MHC class I moleculesQ40898177
The use of HLA A2.1/p53 peptide tetramers to visualize the impact of self tolerance on the TCR repertoireQ40908102
Serial triggering of many T-cell receptors by a few peptide-MHC complexesQ41346263
Cells expressing a major histocompatibility complex class I molecule with a single covalently bound peptide are highly immunogenicQ41373011
Cancer vaccines based on the identification of genes encoding cancer regression antigensQ41459252
The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptideQ41640226
T cell defined tumor antigensQ41642406
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patientsQ41672999
Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivoQ41764334
Production of soluble MHC class II proteins with covalently bound single peptidesQ42068482
Importance of peptide amino and carboxyl termini to the stability of MHC class I moleculesQ43655210
Virus-specific CD8+ T cells in primary and secondary influenza pneumoniaQ45755057
Ligand recognition by alpha beta T cell receptorsQ46222293
Studies on fibronectin and its domains. II. Secondary structure and spatial configuration of fibronectin and of its domains.Q50783798
Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.Q52040367
The repertoire of T cells shaped by a single MHC/peptide ligand.Q52887226
Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.Q53436850
Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNAQ56930699
From TCR Engagement to T Cell ActivationQ57363708
Functional cell surface expression by a recombinant single-chain class I major histocompatibility complex molecule with a cis-active beta 2-microglobulin domainQ72797887
HLA-peptide tetrameric complexesQ77174550
Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosisQ77768045
High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signalingQ77769114
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectEscherichia coliQ25419
refoldingQ3935998
P304page(s)3522-3532
P577publication date2000-12-01
P1433published inEuropean Journal of ImmunologyQ5412727
P1476titleRecombinant human single-chain MHC-peptide complexes made from E. coli By in vitro refolding: functional single-chain MHC-peptide complexes and tetramers with tumor associated antigens.
P478volume30

Reverse relations

cites work (P2860)
Q33357299Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts
Q37789411Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes
Q34035564Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity.
Q46187873Greater expression of TLR2, TLR4, and IL6 due to negative energy balance is associated with lower expression of HLA-DRA and HLA-A in bovine blood neutrophils after intramammary mastitis challenge with Streptococcus uberis
Q34510727HLA class II tetramers: tools for direct analysis of antigen-specific CD4+ T cells
Q34718365Hematopoietic cellular therapy: implications for the flow cytometry laboratory
Q33816520Mammary gene expression profiles during an intramammary challenge reveal potential mechanisms linking negative energy balance with impaired immune response
Q78555137Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes
Q31005351Recombinant antibodies with MHC‐restricted, peptide‐specific, T‐cell receptor‐like specificity: new tools to study antigen presentation and TCR–peptide–MHC interactions
Q33368725Selection of human antibody fragments directed against tumor T-cell epitopes for adoptive T-cell therapy
Q44473369Simultaneous monitoring of binding to and activation of tumor-specific T lymphocytes by peptide-MHC.
Q36297606T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.
Q37987723T-cell-receptor-like antibodies - generation, function and applications
Q37192915Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies
Q34834369Tumor-specific Ab-mediated targeting of MHC-peptide complexes induces regression of human tumor xenografts in vivo

Search more.